INC Research Holdings, Inc. (INCR) Given a $46.00 Price Target at Robert W. Baird
Several other equities analysts have also issued reports on INCR. Goldman Sachs Group, Inc. (The) reiterated a buy rating and issued a $65.00 price target on shares of INC Research Holdings in a research note on Monday, August 7th. Zacks Investment Research lowered INC Research Holdings from a buy rating to a hold rating in a research note on Wednesday, October 4th. TheStreet upgraded INC Research Holdings from a c rating to a b- rating in a research report on Monday, November 6th. Credit Suisse Group reduced their price objective on INC Research Holdings from $68.00 to $54.00 and set an outperform rating on the stock in a research report on Tuesday. Finally, Mizuho initiated coverage on INC Research Holdings in a research report on Thursday, September 21st. They set a neutral rating and a $57.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. INC Research Holdings currently has an average rating of Hold and a consensus price target of $56.33.
Shares of INC Research Holdings (INCR) traded down $0.25 on Thursday, hitting $37.75. The stock had a trading volume of 1,642,576 shares, compared to its average volume of 908,579. INC Research Holdings has a one year low of $33.60 and a one year high of $61.10. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.27 and a current ratio of 1.27. The company has a market cap of $3,970.00 and a price-to-earnings ratio of 15.76.
INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings results on Thursday, November 9th. The company reported $0.54 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.63 by ($0.09). INC Research Holdings had a negative net margin of 4.29% and a positive return on equity of 14.42%. The business had revenue of $592.21 million during the quarter, compared to the consensus estimate of $604.95 million. During the same quarter in the previous year, the business posted $0.64 EPS. The company’s revenue for the quarter was up 128.2% on a year-over-year basis. equities analysts expect that INC Research Holdings will post 2.29 earnings per share for the current fiscal year.
In other INC Research Holdings news, CEO Alistair Macdonald sold 2,348 shares of the company’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $54.60, for a total value of $128,200.80. Following the sale, the chief executive officer now owns 99,453 shares in the company, valued at approximately $5,430,133.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Gregory S. Rush sold 41,420 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $58.26, for a total value of $2,413,129.20. Following the completion of the sale, the chief financial officer now owns 42,793 shares in the company, valued at approximately $2,493,120.18. The disclosure for this sale can be found here. Insiders have sold a total of 189,493 shares of company stock worth $11,059,514 in the last 90 days. 0.24% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lee Thomas H Partners LP bought a new stake in shares of INC Research Holdings in the 3rd quarter valued at about $1,316,644,000. Arizona State Retirement System bought a new stake in shares of INC Research Holdings in the 2nd quarter valued at about $1,336,000. Koch Industries Inc. bought a new stake in shares of INC Research Holdings in the 2nd quarter valued at about $499,000. Personal Capital Advisors Corp bought a new stake in shares of INC Research Holdings in the 3rd quarter valued at about $234,000. Finally, Swiss National Bank grew its position in shares of INC Research Holdings by 2.2% in the 2nd quarter. Swiss National Bank now owns 89,877 shares of the company’s stock valued at $5,258,000 after buying an additional 1,900 shares during the last quarter. Hedge funds and other institutional investors own 77.75% of the company’s stock.
About INC Research Holdings
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.